Literature DB >> 9303196

The design of antisense RNA.

G Sczakiel1.   

Abstract

Antisense nucleic acids comprise short-chain synthetic oligonucleotides, often oligodeoxyribonucleotides (ODN) of less than approximately 30 nucleotides and substantially longer sequences formed by ribonucleic acids (RNA). Both groups differ with respect to several properties, including their generation, the mode of delivery, and their structure-function relationship. Long-chain antisense RNA transcribed in vitro or endogenously from recombinant genes fold into three-dimensional structures. The pairing reaction with their complementary target strand occurs via largely unknown annealing mechanisms and, depending on the phylogenetic cellular background, in different cellular compartments. The annealing pathway is influenced by a variety of biologic and biochemical parameters that are as yet poorly understood. However, the basal biochemical mechanisms underlying the relationship between RNA structure and efficient annealing could allow one to derive more general rules for the design of in vivo effective antisense RNA in a way that is not dependent on specific cell types. Here, some of the criteria are discussed that are currently thought to have major impact on the design of long-chain antisense RNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9303196     DOI: 10.1089/oli.1.1997.7.439

Source DB:  PubMed          Journal:  Antisense Nucleic Acid Drug Dev        ISSN: 1087-2906


  5 in total

1.  Stabilization of the tau exon 10 stem loop alters pre-mRNA splicing.

Authors:  Christine P Donahue; Christina Muratore; Jane Y Wu; Kenneth S Kosik; Michael S Wolfe
Journal:  J Biol Chem       Date:  2006-06-16       Impact factor: 5.157

2.  In vitro selection supports the view of a kinetic control of antisense RNA-mediated inhibition of gene expression in mammalian cells.

Authors:  V Patzel; G Sczakiel
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

3.  Theoretical design of antisense genes with statistically increased efficacy.

Authors:  M J Lehmann; V Patzel; G Sczakiel
Journal:  Nucleic Acids Res       Date:  2000-07-01       Impact factor: 16.971

4.  Dominant genetic screen for cofactors that enhance antisense RNA-mediated gene silencing in fission yeast.

Authors:  Mitch Raponi; Greg M Arndt
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

5.  Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance.

Authors:  D Byrne; C Daly; R Nicamhlaoibh; A Howlett; K Scanlon; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.